The optimal dose, efficacy and safety of tranexamic acid and aminocaproic acid in intravenous and intra-articular administrations to reduce bleeding for patients after TKA: A systematic review and Bayesian network meta-analysis [PDF]
, 2022 che zheng, Jiawen Xu, bin shen
openalex +1 more source
Magnetically controlled protein nanocontainers as a drug depot for the hemostatic agent
Nanotechnology, Science and Applications, 2019 Artur Prilepskii, Alexandra Schekina, Vladimir VinogradovITMO University, International Institute “Solution Chemistry of Advanced Materials and Technologies” (SCAMT), Saint Petersburg 191002, Russian FederationPurpose: Currently, there is a ...
Prilepskii A, Schekina A, Vinogradov V
doaj
Point-of-Care Testing for Prothrombin Time, but Not Activated Partial Thromboplastin Time, Correlates With Laboratory Methods in Patients Receiving Aprotinin or epsilon-Aminocaproic Acid While Undergoing Cardiac Surgery [PDF]
, 2002 Tak-Shun Choi +5 more
openalex +1 more source
ε-aminocaproic Acid in Coronary Artery Bypass Graft Surgery [PDF]
, 2003 Roman Kluger +3 more
openalex +1 more source
Effects of ε-Aminocaproic Acid and Aprotinin on Leukocyte–Platelet Adhesion in Patients Undergoing Cardiac Surgery [PDF]
, 2004 Philip E. Greilich +7 more
openalex +1 more source
The fibrinolytic system attenuates vascular tone: effects of tissue plasminogen activator (tPA) and aminocaproic acid on renal microcirculation [PDF]
, 2004 Samuel N. Heyman +7 more
openalex +1 more source
Are tranexamic acid and ε-aminocaproic acid adequate substitutes for aprotinin?
Annals of Cardiac Anaesthesia, 2012 Deepak K Tempe, Suruchi Hasija
doaj +1 more source
Laboratory measures of hemostasis and fibrinolysis after intravenous administration of ϵ-aminocaproic acid in clinically normal horses and ponies [PDF]
, 2005 Peter Heidmann +3 more
openalex +1 more source